Security Snapshot

NEOGENOMICS INC - Common Stock (NEO) Institutional Ownership

CUSIP: 64049M209

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

255

Shares (Excl. Options)

130,819,531

Price

$11.76

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
NEO on Nasdaq
Shares outstanding
129,668,560
Price per share
$7.42
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
130,819,531
Total reported value
$1,540,501,405
% of total 13F portfolios
0%
Share change
-1,302,636
Value change
+$17,011,573
Number of holders
255
Price from insider filings
$7.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • NEO - NEOGENOMICS INC - Common Stock is tracked under CUSIP 64049M209.
  • 255 institutions reported positions in Q4 2025.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 255 to 33 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,540,501,405 to $6,690,576.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 255 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 64049M209?
CUSIP 64049M209 identifies NEO - NEOGENOMICS INC - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of NEOGENOMICS INC - Common Stock (NEO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $145,614,439 18,861,974 BlackRock, Inc. 30 Sep 2025
First Light Asset Management, LLC 7.6% $73,287,770 9,784,749 Mathew P. Arens 30 Jun 2025
Greenhouse Funds LLLP 5.8% $55,659,291 7,431,147 Greenhouse Funds LLLP 30 Jun 2025
MILLENNIUM MANAGEMENT LLC 5% +0.6% $65,352,954 +$470,252 6,483,428 +0.72% Millennium Management LLC 02 Dec 2025
JANUS HENDERSON GROUP PLC 4.8% $63,315,197 6,165,063 JANUS HENDERSON GROUP PLC 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 2.8% -52% $26,073,366 -$24,761,251 3,566,808 -49% Millennium Management LLC 30 Jun 2025
T. Rowe Price Investment Management, Inc. 2.6% $34,067,326 3,317,169 T. Rowe Price Investment Management, Inc. 31 Mar 2025

As of 31 Dec 2025, 255 institutional investors reported holding 130,819,531 shares of NEOGENOMICS INC - Common Stock (NEO). This represents 101% of the company’s total 129,668,560 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of NEOGENOMICS INC - Common Stock (NEO) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 19,461,349 +0.84% 0% $228,865,463
VANGUARD GROUP INC 11% 13,828,355 -0.54% 0% $162,621,455
First Light Asset Management, LLC 7.7% 10,035,063 +1.1% 9% $118,012,341
Greenhouse Funds LLLP 6.7% 8,643,846 +5.1% 3.9% $101,651,629
D. E. Shaw & Co., Inc. 4.1% 5,297,528 +61% 0.05% $62,298,929
MILLENNIUM MANAGEMENT LLC 4% 5,204,409 -13% 0.04% $61,203,850
STATE STREET CORP 3.8% 4,978,292 -0.88% 0% $58,544,714
BRAIDWELL LP 3.6% 4,632,801 +162% 1.7% $54,481,740
SCHRODER INVESTMENT MANAGEMENT GROUP 3.1% 4,017,588 +15% 0.04% $49,135,101
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 3% 3,939,140 0% 0.07% $46,324,000
GEODE CAPITAL MANAGEMENT, LLC 2.4% 3,176,644 +1.4% 0% $37,363,823
Driehaus Capital Management LLC 1.9% 2,471,738 0.2% $29,067,639
DIMENSIONAL FUND ADVISORS LP 1.9% 2,448,747 -36% 0.01% $28,801,373
AMERICAN CAPITAL MANAGEMENT INC 1.8% 2,324,366 -0.89% 1.2% $27,334,544
GW&K Investment Management, LLC 1.7% 2,238,767 +7.5% 0.23% $26,328,000
T. Rowe Price Investment Management, Inc. 1.7% 2,218,727 +70% 0.02% $26,093,000
MORGAN STANLEY 1.6% 2,126,048 -20% 0% $25,002,339
Aberdeen Group plc 1.4% 1,798,939 +127% 0.03% $21,155,523
SEGALL BRYANT & HAMILL, LLC 1.3% 1,732,029 -4.6% 0.28% $20,368,661
PFM Health Sciences, LP 1.3% 1,694,051 -23% 2% $19,922,040
LOOMIS SAYLES & CO L P 1.3% 1,631,135 0.02% $19,182,147
GOLDMAN SACHS GROUP INC 1.1% 1,433,130 -21% 0% $16,853,609
NORTHERN TRUST CORP 1.1% 1,423,088 -4.5% 0% $16,735,514
GLENMEDE TRUST CO NA 1.1% 1,410,835 0% 0.08% $16,591,418
SAMLYN CAPITAL, LLC 1.1% 1,388,221 0.26% $16,325,479

Institutional Holders of NEOGENOMICS INC - Common Stock (NEO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 900,042 $6,690,576 -$40,215 $7.42 33
2025 Q4 130,819,531 $1,540,501,405 +$17,011,573 $11.76 255
2025 Q3 128,856,828 $995,144,233 +$13,772,890 $7.72 251
2025 Q2 127,102,311 $928,960,411 -$11,861,045 $7.31 269
2025 Q1 126,074,888 $1,197,235,152 +$20,732,141 $9.49 248
2024 Q4 122,630,250 $2,020,773,423 -$19,292,481 $16.48 247
2024 Q3 123,905,582 $1,824,489,746 -$30,173,686 $14.75 265
2024 Q2 125,764,461 $1,744,349,407 -$25,594,791 $13.87 253
2024 Q1 128,566,414 $2,021,077,127 +$40,223,752 $15.72 260
2023 Q4 125,750,435 $2,034,740,144 +$91,247,148 $16.18 282
2023 Q3 120,319,823 $1,480,068,392 +$31,109,122 $12.30 278
2023 Q2 117,354,505 $1,887,976,537 +$17,892,372 $16.07 261
2023 Q1 116,149,860 $2,022,087,874 +$68,408,756 $17.41 250
2022 Q4 112,517,309 $1,039,664,895 +$6,813,825 $9.24 235
2022 Q3 112,517,984 $968,760,212 -$61,344,388 $8.61 236
2022 Q2 117,343,229 $956,378,739 +$558,727 $8.15 222
2022 Q1 110,849,435 $1,347,014,006 -$178,663,861 $12.15 262
2021 Q4 117,712,710 $4,016,513,724 +$21,819,286 $34.12 302
2021 Q3 115,633,668 $5,577,437,288 +$212,796,154 $48.24 318
2021 Q2 111,349,475 $5,028,565,162 +$185,109,189 $45.17 308
2021 Q1 108,007,395 $5,210,316,095 +$250,630,845 $48.23 326
2020 Q4 103,918,826 $5,595,174,116 +$117,101,727 $53.84 336
2020 Q3 101,942,927 $3,761,276,674 -$19,415,173 $36.89 287
2020 Q2 102,197,271 $3,169,534,118 +$257,605,485 $30.98 278
2020 Q1 94,250,581 $2,602,301,782 +$27,489,034 $27.61 268
2019 Q4 93,293,806 $2,729,193,664 +$45,246,831 $29.25 256
2019 Q3 87,125,777 $1,666,829,605 -$18,906,455 $19.12 250
2019 Q2 88,011,895 $1,931,168,758 +$197,590,212 $21.94 248
2019 Q1 80,297,232 $1,642,983,621 +$187,689,737 $20.46 233
2018 Q4 73,228,993 $923,350,595 -$106,969,804 $12.61 208
2018 Q3 78,268,426 $1,201,373,536 +$180,649,386 $15.35 164
2018 Q2 66,397,194 $870,489,639 -$6,688,369 $13.11 143
2018 Q1 67,156,673 $547,974,435 -$10,155,435 $8.16 135
2017 Q4 68,148,564 $603,905,922 +$5,682,788 $8.86 129
2017 Q3 64,947,437 $722,851,068 +$28,008,991 $11.13 134
2017 Q2 63,838,104 $571,988,977 +$44,934,711 $8.96 131
2017 Q1 60,986,845 $481,207,391 +$23,029,142 $7.89 141
2016 Q4 61,501,727 $527,231,747 +$18,944,072 $8.57 140
2016 Q3 59,851,989 $491,918,704 -$2,099,005 $8.22 133
2016 Q2 60,134,314 $483,480,965 +$27,704,279 $8.04 151
2016 Q1 56,624,535 $381,504,957 +$7,891,052 $6.74 118
2015 Q4 54,868,907 $432,011,156 +$134,220,930 $7.87 118
2015 Q3 38,367,448 $219,844,269 +$5,992,846 $5.73 98
2015 Q2 37,342,452 $202,024,034 +$12,890,004 $5.41 95
2015 Q1 34,054,690 $158,949,783 +$4,305,119 $4.67 82
2014 Q4 33,383,734 $139,169,586 -$2,651,371 $4.17 86
2014 Q3 33,588,347 $175,023,485 +$52,954,403 $5.21 84
2014 Q2 23,824,208 $79,094,455 +$507,392 $3.32 67
2014 Q1 23,752,378 $82,403,424 +$3,357,717 $3.47 68